Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury
NCT ID: NCT05740553
Last Updated: 2023-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2021-11-15
2022-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Training System Using Electroencephalography (EEG) for Neurorehabilitation of Hand Function After Stroke
NCT02323074
Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments
NCT05479006
Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-stroke Hemiparesis
NCT04574973
Restoring Grasp Ability in Stroke Survivors Through MI-Based Training
NCT06307834
Brain Computer Interface (BCI) Technology for Stroke Hand Rehabilitation
NCT01287975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the study, participants will have a ReTrieve tactile training system delivered home for use over 6 weeks. Investigators will take three days to teach participants how to use the system. Each week for the remainder of the 6 weeks, participants will use this system for 4+ days per week on their own, and for 1 day supervised. During each supervised day, participants will complete approximately 1 hour of training while supervised over video chat with researchers.
Participants' tactile function will be assessed at three separate time points: once within one week before beginning training, once within one week after completing training, as well as once either 8 weeks before or 8 weeks after the training. This assessment has a required survey component, as well as an optional in-person clinical assessment component.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training First
ReTrieve Automated Stereognosis System
An automated tactile training system that may help patients recover lost tactile function after brain injury.
Training Second
ReTrieve Automated Stereognosis System
An automated tactile training system that may help patients recover lost tactile function after brain injury.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ReTrieve Automated Stereognosis System
An automated tactile training system that may help patients recover lost tactile function after brain injury.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able to communicate and consent for themselves
* Have experienced a brain injury more than 6 months prior to the date of study participation
* Have chronic tactile deficits in at least one hand as a result of their brain injury
* Have sufficient motor ability in their affected hand(s) to complete reach and grasp tasks
* Have sufficient motor ability in their affected hand(s) to raise their arms above their head
* Have sufficient motor ability in their affected hand(s) to hold objects
* Have wireless internet and a laptop or mobile device at home for video conferencing
* Live in the greater Dallas area
Exclusion Criteria
* Significant communication deficits that would preclude them from consenting for themselves
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas at Dallas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas at Dallas
Richardson, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.